The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A.   Davidson P.   Atkinson C.   Hart D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Immune responses in patients with esophageal cancer treated with SART1 peptidepulsed dendritic cell vaccine

By                        

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1699-1709

Spandidos Publications

Access to resources Recommend Favorite

SLC gene-modified dendritic cells mediate T cell-dependent anti-gastric cancer immune responses in vitro

By              

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 595-604

Spandidos Publications

Access to resources Recommend Favorite

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy

By Merrick Alison   Diaz Rosa   O’Donnell Dearbhaile   Selby Peter   Vile Richard   Melcher Alan  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 897-906

Springer Publishing Company

Access to resources Recommend Favorite

Tumour escape from immune surveillance through dendritic cell inactivation

By Vicari A.P.   Caux C.   Trinchieri G.  

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 33-42

Academic Press

Access to resources Recommend Favorite